Arto Leminen

3.4k total citations
60 papers, 1.9k citations indexed

About

Arto Leminen is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Oncology. According to data from OpenAlex, Arto Leminen has authored 60 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Obstetrics and Gynecology, 19 papers in Reproductive Medicine and 16 papers in Oncology. Recurrent topics in Arto Leminen's work include Endometrial and Cervical Cancer Treatments (22 papers), Ovarian cancer diagnosis and treatment (12 papers) and Uterine Myomas and Treatments (12 papers). Arto Leminen is often cited by papers focused on Endometrial and Cervical Cancer Treatments (22 papers), Ovarian cancer diagnosis and treatment (12 papers) and Uterine Myomas and Treatments (12 papers). Arto Leminen collaborates with scholars based in Finland, United States and China. Arto Leminen's co-authors include Ralf Bützow, Pentti Lehtovirta, Mikko Loukovaara, Heini Lassus, Riitta Koivisto-Korander, M Forss, Torsten Wahlström, Anna‐Maija Koivisto, Eero Pukkala and Jorma Isola and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Cancer and Cancer Research.

In The Last Decade

Arto Leminen

60 papers receiving 1.9k citations

Peers

Countries citing papers authored by Arto Leminen

Since Specialization

Citations

This map shows the geographic impact of Arto Leminen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arto Leminen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arto Leminen more than expected).

Fields of papers citing papers by Arto Leminen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arto Leminen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arto Leminen. The network helps show where Arto Leminen may publish in the future.

Co-authorship network of co-authors of Arto Leminen

This figure shows the co-authorship network connecting the top 25 collaborators of Arto Leminen. A scholar is included among the top collaborators of Arto Leminen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arto Leminen. Arto Leminen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prediction of lymphatic dissemination in endometrioid endometrial cancer: Comparison of three risk-stratification models in a single-institution cohort 2017 ·Gynecologic Oncology ·(unknown), Annukka Pasanen, Arto Leminen, Ralf Bützow, Mikko Loukovaara	12
2	Health-related quality of life and perception of anxiety in women with abnormal cervical cytology referred for colposcopy: an observational study 2013 ·European Journal of Obstetrics & Gynecology and Reproductive Biology ·(unknown), Anna‐Maija Tapper, Arto Leminen, Harri Sintonen, Risto P. Roine	31
3	A Combined Array-Based Comparative Genomic Hybridization and Functional Library Screening Approach Identifies mir-30d As an Oncomir in Cancer 2011 ·Cancer Research ·(unknown), Sippy Kaur, Joel Greshock, Heini Lassus, Xiaomin Zhong, Yanling Wang, Arto Leminen, Zhongjun Shao, Zhongyi Hu, Shun Liang, Dionyssios Katsaros, Qihong Huang, Ralf Bützow, Barbara L. Weber, George Coukos, Lin Zhang	44
4	Oxaliplatin scale and National Cancer Institute-Common Toxicity Criteria in the assessment of chemotherapy-induced peripheral neuropathy. 2011 ·PubMed ·Anna-Liisa Kautio, Maija Haanpää, Hannu Kautiainen, Arto Leminen, Eija Kalso, Tiina Saarto	27
5	Immunohistochemical studies on uterine carcinosarcoma, leiomyosarcoma, and endometrial stromal sarcoma: expression and prognostic importance of ten different markers 2010 ·Tumor Biology ·Riitta Koivisto-Korander, Ralf Bützow, Anna‐Maija Koivisto, Arto Leminen	57
6	Costs and health‐related quality of life effects of hysterectomy in patients with benign uterine disorders 2009 ·Acta Obstetricia Et Gynecologica Scandinavica ·(unknown), Arto Leminen, Pirjo Räsänen, (unknown), Anna‐Maija Tapper, Harri Sintonen, Risto P. Roine, (unknown)	27
7	Tissue AP-2γ and Oct-3/4, and Serum CA 125 as Diagnostic and Prognostic Markers of Malignant Ovarian Germ Cell Tumors 2008 ·Tumor Biology ·(unknown), Arto Leminen, Ulf‐Håkan Stenman, (unknown), Markku Heikinheimo, Oskari Heikinheimo	7
8	Biweekly docetaxel in recurrent ovarian cancer: a phase I dose finding study 2008 ·Cancer Chemotherapy and Pharmacology ·Johanna Mäenpää, Arto Leminen	4
9	Clinical outcome and prognostic factors in 100 cases of uterine sarcoma: Experience in Helsinki University Central Hospital 1990–2001 2008 ·Gynecologic Oncology ·Riitta Koivisto-Korander, Ralf Bützow, Anna‐Maija Koivisto, Arto Leminen	57
10	Distinct expression profile in fumarate-hydratase-deficient uterine fibroids 2005 ·Human Molecular Genetics ·Sakari Vanharanta, Patrick J. Pollard, Heli Lehtonen, Päivi Laiho, Jari Sjöberg, Arto Leminen, Kristiina Aittomäki, Johanna Arola, Mogens Kruhøffer, Torben F. Ørntoft, Ian Tomlinson, Maija Kiuru, Diego Arango, Lauri A. Aaltonen	51
11	Advanced cervical pregnancy: uterus-sparing therapy initiated with a combination of methotrexate and mifepristone followed by evacuation and local hemostatic measures 2004 ·Acta Obstetricia Et Gynecologica Scandinavica ·Oskari Heikinheimo, Arto Leminen, Bruno Cacciatore, Eeva‐Marja Rutanen, Pauli Kajanoja	10
12	Advanced cervical pregnancy: uterus‐sparing therapy initiated with a combination of methotrexate and mifepristone followed by evacuation and local hemostatic measures 2004 ·Acta Obstetricia Et Gynecologica Scandinavica ·Oskari Heikinheimo, Arto Leminen, Bruno Cacciatore, Eeva‐Marja Rutanen, Pauli Kajanoja	12
13	Ezrin immunoreactivity in relation to survival in serous ovarian carcinoma patients 2003 ·Gynecologic Oncology ·Jarna Moilanen, Heini Lassus, Arto Leminen, Antti Vaheri, Ralf Bützow, Olli Carpén	77
14	Collagenases (MMP-1, -8 and -13) and Trypsinogen-2 in Fluid from Benign and Malignant Ovarian Cysts 2003 ·Tumor Biology ·Mathias Stenman, Annukka Paju, Roeland Hanemaaijer, Taina Tervahartiala, Arto Leminen, Ulf‐Håkan Stenman, (unknown), Timo Sorsa	25
15	Incidence of cancer among women using long versus monthly cycle hormonal replacement therapy, Finland 1994–1997 2001 ·Cancer Causes & Control ·Eero Pukkala, (unknown), Arto Leminen	39
16	Spread of Ovarian Cancer after Laparoscopic Surgery: Report of Eight Cases 1999 ·Gynecologic Oncology ·Arto Leminen, Pentti Lehtovirta	55
17	Therapeutic and prognostic considerations in primary carcinoma of the vagina 1995 ·Acta Obstetricia Et Gynecologica Scandinavica ·Arto Leminen, M Forss, Pentti Lehtovirta	12
18	Pre‐ and posttreatment serum antibody responses to HPV 16 E2 and HSV 2 ICP8 proteins in women with cervical carcinoma 1992 ·Journal of Medical Virology ·Matti Lehtinen, Arto Leminen, Tapio Kuoppala, Mirja Tiikkainen, Tuula Lehtinen, Pentti Lehtovirta, R. Punnonen, E Vesterinen, Jorma Paavonen	24
19	Human Papillomavirus Types 16 and 18 in Adenocarcinoma of the Uterine Cervix 1991 ·American Journal of Clinical Pathology ·Arto Leminen, Jorma Paavonen, E Vesterinen, Torsten Wahlström, Immo Rantala, Matti Lehtinen	39
20	Deoxyribonucleic acid flow cytometric analysis of cervical adenocarcinoma: Prognostic significance of deoxyribonucleic acid ploidy and S-phase fraction 1990 ·American Journal of Obstetrics and Gynecology ·Arto Leminen, Jorma Paavonen, E Vesterinen, M Forss, Torsten Wahlström, (unknown), Matti Lehtinen	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact